It sits on the shelf in every hospital around the world, and when used in low doses, may offer stunning benefits for mitochondrial health, treating urinary tract infections, slowing brain aging as well as dementia, Parkinson’s, and other neural injuries caused by stroke and brain injury. Download Interview Transcript | Download my FREE Podcast
STORY AT-A-GLANCE Methylene blue helps mitochondrial respiration and improves brain energy metabolism. By doing that, it can improve cognitive performance and prevent neurodegeneration.
Methylene blue is the parent molecule for hydroxychloroquine and chloroquine, off-patent drugs commonly used to treat not only malaria but also COVID-19.
Emergency rooms around the world use it, as it’s the only known antidote for metabolic poisons causing methemoglobinemia, which is when a metabolic poison interferes with the transport of oxygen in hemoglobin.
Methylene blue is a hormetic drug, so low doses have the opposite effect of high doses.
Low doses, 0.5 mg to one mg per kilo of bodyweight, are recommended for non-acute, longer-term treatments. Uses include the prevention and treatment of dementia, post-stroke and other brain injuries, cognitive enhancement, and the general optimization of health if you’re already healthy. In this interview, Francisco Gonzalez-Lima, Ph.D., discusses a powerful strategy to improve your mitochondria, which generate the vast majority of the energy your cells produce from food….
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta